Stock TRVN TREVENA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Trevena, Inc.

Equities

TRVN

US89532E2081

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-18 pm EDT 		5-day change 1st Jan Change
0.366 USD -8.96% Intraday chart for Trevena, Inc. -11.38% -49.31%
Apr. 01 Trevena, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 01 Trevena, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Trevena, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Trevena: Q4 Earnings Snapshot
AQ
Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update
AQ
Trevena : Reports Fourth Quarter 2023 Results and Provides Corporate Update - Form 8-K
PU
Trevena, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Trevena, Inc. Promotion of Barry Shin to the Position of Executive Vice President and Chief Operating Officer
CI
Trevena Raises $4 Million via Placement, Warrant Exercise
MT
Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise
AQ
Trevena, Inc. announced that it has received $1.945934 million in funding
CI
Trevena to Raise $4 Million From Private Placement, Warrants Exercise Agreements
MT
Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise
AQ
Trevena, Inc. announced that it expects to receive $1.945934 million in funding
CI
Trevena Announces TRV045 Presentation at the American College of Neuropsychopharmacology 62nd Annual Meeting
AQ
Trevena Awarded OLINVYK Agreement with Premier, Inc.
AQ
Trevena Inc. Receives OLINVYK Agreement with Premier, Inc
CI
Trevena Files $200 Million Mixed Shelf
MT
Trevena Announces Acceptance of Abstract Examining the Use of OLINVYK in Patients with Acute Burn Injuries
AQ
Trevena, Inc. Announces Acceptance of Abstract Examining the Use of Olinvyk in Patients with Acute Burn Injuries
CI
Transcript : Trevena, Inc., Q3 2023 Earnings Call, Nov 14, 2023
Trevena: Q3 Earnings Snapshot
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TRVN Stock
  4. News Trevena, Inc.